CRISPR and RNAi Genetic Screens, Libraries and Construct; Sequencing; RNA Expression Profiling; Barcode Libraries
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
9
NCT00925275
Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 30, 2009
Completion: Feb 28, 2010
Loading map...